PROCEPT BioRobotics Corporation Sued for Securities Law Violations
DJS Law Group reminds investors of a class action lawsuit filed against PROCEPT BioRobotics Corporation for alleged violations of securities laws. The lawsuit concerns statements made by the company between May 2023 and February 2024.
PROCEPT BioRobotics Corporation (NASDAQ: PRCT) faces a class action lawsuit filed in Los Angeles, California. DJS Law Group notified investors on July 31, 2026, of the lawsuit, which alleges violations of securities laws. The case specifically covers the period from May 2023 through February 2024.
The lawsuit claims that Procept and its officers violated §§ 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder. The allegations suggest the company made materially false or misleading statements regarding the safety and efficacy of its urological and gynecological devices, particularly its Aquablation technology.
Investors who purchased PROCEPT BioRobotics Corporation stock during the specified period are encouraged to contact DJS Law Group to discuss their legal rights and potential involvement in the class action. The suit aims to represent shareholders who relied on the company's public statements when making investment decisions.
Procept BioRobotics Corporation is a medical device company focused on developing robotic solutions for urological and gynecological conditions. The company's stock is traded on the NASDAQ exchange under the ticker symbol PRCT.